BioCentury
ARTICLE | Clinical News

Affitech, Peregrine preclinical data

November 16, 2009 8:00 AM UTC

In a mouse model of breast cancer, r84 inhibited cancer growth at least as well as Avastin bevacizumab and Sutent sunitinib and was superior to both drugs in limiting the presence of immunosuppressi...